Showing results (1911-1920 of 1,946) with videos related to

Sort By:
Pageof 195
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Leukemia|July 21, 2006
International uniform response criteria for multiple myelomaB G M Durie, J-L Harousseau, J S Miguel, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER - Breast Tumors that Lead to Poor OutcomeRobert Ys Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Ys Cheng, et al.
Elife|April 27, 2016
The global antigenic diversity of swine influenza A virusesNicola S Lewis, Colin A Russell, Pinky Langat, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Reducing Door-to-Reperfusion Time for Mechanical Thrombectomy With a Multitiered Notification System for Acute Ischemic StrokeEric D Goldstein, Lynda Schnusenberg, Lesia Mooney, et al.
Cell Death & Disease|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcomeRobert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Redox Biology|November 14, 2022
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and densityVeena Somasundaram, Lisa A Ridnour, Robert Ys Cheng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancerA-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
JCI Insight|July 15, 2025
Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER- breast cancerLisa A Ridnour, Robert Ys Cheng, William F Heinz, et al.
Pageof 195